EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Countywide burden, pathology, and genetics of lethal hypertrophic cardiomyopathy: from the POST SCD study

Leila Haghighat iD, Andrew Connolly, Francesca Nesta Delling iD, Theodore Pravinchandra Abraham iD, Ellen Moffatt, Zian H Tseng iD

Europace · 2025

DOI: 10.1093/europace/euaf088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Europace, 2025. Verfasst von Leila Haghighat und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, University of California-San Francisco, San Francisco, 500 Parnassus Avenue, Box 1354, CA 94143-1354,…. Hauptthemen laut MEDLINE: Death, Sudden, Cardiac, Cardiomyopathy, Hypertrophic. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Incidence of sudden cardiac death (SCD) is 1%/year in cohorts with hypertrophic cardiomyopathy (HCM), but this estimate presumes arrhythmic cause and misses occult cases dying before diagnosis. Methods and results POST SCD (POstmortem Systematic InvesTigation of Sudden Cardiac Death) is a prospective cohort study using autopsy, clinical records, and toxicology to adjudicate arrhythmic or non-arrhythmic causes among presumed SCDs (pSCDs) meeting WHO criteria aged 0–90 years in San Francisco County. We included all incident cases 2/1/2011–3/1/2014 (n = 525) and approximately every third day 3/1/2014–9/1/2022 (n = 497) based on medical examiner call schedule. We identified HCM victims via three approaches: (i) pathology; (ii) echocardiogram [transthoracic echocardiogram (TTE)]; (iii) genetic criteria. Incidence calculations used county data and estimated HCM prevalence of 1:500 from studies of persons aged 23–35 years old. Of 1022 pSCDs [558 (54.6%) arrhythmic deaths] during the study period, 13 had HCM: 10 met pathology criteria; 2 via review of 203 TTEs (missed on initial report); 1 via genetic testing. Of these, 11 were arrhythmic deaths, yielding 1.3% burden of sudden death (pSCD) and 2% of arrhythmic death. Only 2 of 13 (15%) pSCDs with HCM had pre-mortem diagnosis. Incidence for persons with HCM 18–35 years old was 0.2% pSCDs/year and 0.1% SADs/year. pSCDs with HCM had a higher proportion of arrhythmic cause [11/13 (85%) vs. 547/1009 (54%), P = 0.03] than those without. pSCD burden due to HCM decreased with age (P = 0.003), highest among victims <35 years old, for whom HCM accounted for 7.1% of pSCD and 9.4% of arrhythmic death. Genetic testing of 317 consented pSCDs yielded pathogenic or likely pathogenic variants in 40% (2/5) and identified one additional case without clinical phenotype.

Conclusion

In this 11-year countywide post-mortem study, HCM meeting pathologic, clinical, or genetic criteria was associated with autopsy-confirmed arrhythmic cause of sudden death, accounting for 2% of SADs up to age 90, highest in cases <35 years old. Since 85% of cases were undiagnosed before pSCD, the true burden of HCM-related sudden death may be substantially underestimated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Death, Sudden, CardiacCardiomyopathy, HypertrophicHumansAdultMaleMiddle AgedFemaleAdolescentYoung AdultChildAgedChild, PreschoolIncidenceInfantProspective StudiesAged, 80 and overAutopsyGenetic Predisposition to DiseaseSan FranciscoRisk FactorsInfant, NewbornEchocardiography

Stichwörter der Autor:innen

Sudden deatharrhythmic deathcardiac geneticshypertrophic cardiomyopathy

Autor:innen und Institutionen

  • Division of Cardiology, Department of Medicine, University of California-San Francisco, San Francisco, 500 Parnassus Avenue, Box 1354, CA 94143-1354, USA.
  • Department of Pathology and Laboratory Medicine, University of California-San Francisco, San Francisco, CA, USA.
  • Office of the Chief Medical Examiner, San Francisco, CA, USA.

ORCID-Profile: Leila Haghighat, Francesca Nesta Delling, Theodore Pravinchandra Abraham, Zian H Tseng

Förderung

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Haghighat, L., Connolly, A., Delling, F. N., Abraham, T. P., Moffatt, E., & Tseng, Z. H. (2025). Countywide burden, pathology, and genetics of lethal hypertrophic cardiomyopathy: from the POST SCD study. Europace. https://doi.org/10.1093/europace/euaf088

Vancouver

Haghighat L, Connolly A, Delling FN, Abraham TP, Moffatt E, Tseng ZH. Countywide burden, pathology, and genetics of lethal hypertrophic cardiomyopathy: from the POST SCD study. Europace. 2025. doi:10.1093/europace/euaf088

BibTeX
@article{Haghighat2025,
  author = {Haghighat, Leila and Connolly, Andrew and Delling, Francesca Nesta and Abraham, Theodore Pravinchandra and Moffatt, Ellen and Tseng, Zian H},
  title = {Countywide burden, pathology, and genetics of lethal hypertrophic cardiomyopathy: from the POST SCD study},
  journal = {Europace},
  year = {2025},
  doi = {10.1093/europace/euaf088}
}
Kostenlos starten →